--- title: Oncology CROs in Asia-Pacific path: /indications/oncology/apac companies_count: 32 --- # Oncology CROs in Asia-Pacific 32 published CROs match Oncology in Asia-Pacific. Locations in this set include United States, China, Australia, India, United Kingdom, and Japan. Capabilities that show up most often in this set: Phase II Clinical Trials, Phase III Clinical Trials, Clinical Operations, Phase IV / Post-Marketing, and Data Management & eClinical. ## Matching companies - [Aragen Life Sciences](/companies/aragen) - Global CRDMO partner offering integrated discovery-to-commercialization services across small molecules and biologics, with 4000+ scientists and R&D/manufacturing campuses in Asia, North America, and Europe. - [Avion](/companies/avion) - Full-service CRO specializing in clinical trial management, advanced medical imaging, dosimetry, and data management across oncology, dermatology, and radiopharmaceutical therapies. - [Charles River Laboratories](/companies/criver) - Charles River Laboratories provides contract research, development, and manufacturing services across the full drug discovery and development continuum, supporting 80% of FDA-approved drugs over the past five years. - [ChemDiv](/companies/chemdiv) - ChemDiv is a fully integrated target-to-clinic CRO headquartered in San Diego, CA, offering drug discovery services including medicinal chemistry, CADD, ADME/DMPK, toxicology, and custom synthesis alongside the industry's largest commercial screening library of 1.6M compounds. - [ChemPartner](/companies/chempartner) - Global preclinical CRO with 20+ years of experience supporting drug discovery through IND submission across small molecules and biologics, with 2,000+ scientists and facilities worldwide. - [ClinActis Pte Ltd](/companies/clinactis) - Full-service CRO delivering clinical trial services across Asia Pacific, with 50+ years of cumulative experience managing Phase I–IV trials and expertise in oncology, cardiovascular, CNS, and infectious disease indications. - [Clinical Research Network India Pvt. Ltd.](/companies/crnindia) - Clinical Research Organization offering Phase I–IV clinical trials, pharmacovigilance, medical writing, regulatory affairs, and data management services with 15+ years of experience across cardiology, oncology, vaccines, and medical devices. - [Crown Bioscience](/companies/crownbio) - Preclinical oncology CRO offering 2,500+ PDX models, organoid and cell line databases, and translational platforms with biomarker discovery and AI-driven systems biology for drug development. - [Emerald Clinical](/companies/emeraldclinical) - Global clinical research organization with 25+ years of expertise, headquartered in Singapore with operations across Asia-Pacific, EMEA, and the Americas. Specializes in renal, oncology, cardiovascular, and early-phase research with deep scientific leadership and proven operational excellence. - [Fortrea](/companies/fortrea) - Fortrea is a leading CRO advancing clinical trials through patient-focused clinical solutions that accelerate clinical development and drive trial success. - [GemPharmatech](/companies/gempharmatech) - GemPharmatech develops and supplies genetically engineered mouse models (GEMMs) and preclinical research services using CRISPR/Cas9 and gene-editing technologies, with a library of 25,000+ mouse strains including KO/cKO, humanized, and immunodeficient models. - [HitGen Inc.](/companies/hitgen) - HitGen Inc. provides drug discovery services built on DNA-encoded library (DEL), fragment-based (FBDD/SBDD) and computational platforms for pharmaceutical and biotech clients. The company also offers oligonucleotide CDMO services and reports serving more than 600 clients globally. - [ICON plc](/companies/iconplc) - ICON is a global clinical research organization providing full-service drug development and clinical trial solutions across early phase through post-marketing, including clinical operations, bioanalytical labs, cardiac safety, medical imaging, and regulatory affairs. - [IPM Biotech](/companies/ipmbiotech) - IPM Biotech (生创精准医疗科技有限公司) is a cell technology and regenerative medicine company founded in 2015 by a team of renowned returnee scientists specializing in stem cells and regenerative medicine. - [JSS Medical Research](/companies/jssresearch) - Full-service CRO with over 30 years of experience offering clinical trials, biostatistics, medical writing, and health economics services across all phases of development. - [KCAS Bio](/companies/kcasbio) - Leading bioanalytical CRO with 45+ years of experience, supporting 315+ approved drugs through bioanalysis, biomarker, immunogenicity, flow cytometry, and clinical kitting services across US, EU, and Australia facilities. - [LIDE Biotech](/companies/lide-biotech) - Oncology-focused preclinical CRO with AAALAC-accredited China-based labs offering 2300+ PDX models, MiniPDX organoid assays, and multi-omics analysis for drug discovery and development. - [Linical](/companies/linical) - Global, award-winning CRO guiding clinical development from early-phase research to large-scale global studies with 90% client retention. - [Novotech](/companies/novotech-cro) - Global full-service CRO specializing in early-phase and oncology trials across 50+ countries, with expertise in cardiovascular, cell and gene therapy, and radiopharmaceutical development. - [PPD](/companies/ppd) - PPD is a leading global contract research organization (CRO) and the clinical research business of Thermo Fisher Scientific.